Stability of rare TP53 co-mutations in AML patients.

被引：0

作者：

Bloom, Kenneth Joel

Idica, Adam

Smart, Dave

Allen, Wendy

Scanlon, Enya

Clark, Jordan

机构：

[1] Clarient Diagnost Serv Inc, Aliso Viejo, CA USA

[2] DIACEUTICS, Carlsbad, CA USA

[3] Diaceutics, Belfast, Antrim, North Ireland

[4] Queens Univ Belfast, Belfast, Antrim, North Ireland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7528

引用

页数：2

共 50 条

[31] Pathogenic TP53 mutations Are Associated with a Poor Prognosis in De Novo AML
Lamble, Adam J.
Ries, Rhonda E.
Dang, Alice
Alonzo, Todd A.
Chisholm, Karen
Kolekar, Pandurang
Liu, Yanling
Tran, Quang
Cooper, Todd M.
Aplenc, Richard
Gamis, Alan S.
Kolb, Edward A.
Ma, Xiaotu
Meshinchi, Soheil
BLOOD, 2022, 140 : 6297 - 6298
[32] Surveillance recommendations for patients with germline TP53 mutations
Ballinger, Mandy L.
Mitchell, Gillian
Thomas, David M.
CURRENT OPINION IN ONCOLOGY, 2015, 27 (04) : 332 - 337
[33] TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
Sallman, David A.
McLemore, Amy F.
Aldrich, Amy L.
Komrokji, Rami S.
McGraw, Kathy L.
Dhawan, Abhishek
Geyer, Susan
Hou, Hsin-An
Eksioglu, Erika Adriana
Sullivan, Amy
Warren, Sarah
MacBeth, Kyle J.
Meggendorfer, Manja
Haferlach, Torsten
Boettcher, Steffen
Ebert, Benjamin L.
Al-Ali, Najla
Lancet, Jeffrey E.
Cleveland, John L.
Padron, Eric
List, Alan F.
BLOOD, 2020, 136 (24) : 2812 - 2823
[34] TP53 mutations in Romanian patients with colorectal cancer
Manirakiza, Felix
Yamada, Hidetaka
Iwashita, Yuji
Ishino, Keiko
Ishikawa, Rei
Kovacs, Zsolt
Osvath, Eva
Nzitakera, Augustin
Gurzu, Simona
Sugimura, Haruhiko
GENES AND ENVIRONMENT, 2023, 45 (01)
[35] The Predictive Value of TP53 FISH Analysis for Treatment Response and Survival in Cytogenetic Subgroups of AML Patients.
Tavor, Sigal
Rothman, Rachel
Golan, Tamar
Voskoboinik, Nadia
Shomrat, Ruth
Orr-Urtreger, Avi
Naparstek, Elizabeth
BLOOD, 2009, 114 (22) : 1026 - 1027
[36] Negative prognostic impact of Co-mutations in TGFβ and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy
Qian, Chengyuan
Yang, Weina
Li, Mengxia
Feng, Yan
Dai, Nan
Luo, Hao
Jian, Dan
Li, Xuemei
Yang, Yuxin
He, Yue
Wang, Dong
Li, Chunxue
Xiao, He
EJSO, 2024, 50 (04):
[37] TP53 gene mutations are rare in nondysplastic Barrett's esophagus
Novotna, K
Trkova, M
Pazdro, A
Smejkal, M
Soukupova, A
Kodetova, D
Smejkal, P
Sedlacek, Z
DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (01) : 110 - 113
[38] Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
Ciurea, Stefan O.
Chilkulwar, Abhishek
Saliba, Rima M.
Chen, Julianne
Rondon, Gabriela
Patel, Keyur P.
Khogeer, Haitham
Shah, Abdul R.
Randolph, Brion V.
Perez, Jorge M. Ramos
Popat, Uday
Hosing, Chitra M.
Bashir, Qaiser
Mehta, Rohtesh
Al-Atrash, Gheath
Im, Jin
Khouri, Issa F.
Kebriaei, Partow
Champlin, Richard E.
BLOOD, 2018, 131 (26) : 2989 - 2992
[39] Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome
Ferrari, Anna
Papayannidis, Cristina
Baldazzi, Carmen
Iacobucci, Ilaria
Paolini, Stefania
Padella, Antonella
Guadagnuolo, Viviana
Perricone, Margherita
Robustelli, Valentina
Venturi, Claudia
Abbenante, Maria Chiara
Parisi, Sarah
Sartor, Chiara
Volpato, Francesca
Testoni, Nicoletta
Simonetti, Giorgia
Ottaviani, Emanuela
Martinelli, Giovanni
BLOOD, 2014, 124 (21)
[40] 17P DELETIONS AND TP53 MUTATIONS IN PATIENTS WITH MDS/AML AND COMPLEX ABERRANT KARYOTYPE
Schaab, R.
Ganster, C.
Dierks, S.
Parra, M. Tallo
Martin, R.
Germing, U.
Platzbecker, U.
Shirneshan, K.
Lange, F.
Kroeger, N.
Doehner, K.
Glass, B.
Bacher, U.
Haase, D.
HAEMATOLOGICA, 2016, 101 : 68 - 68

← 1 2 3 4 5 →